Article type
Abstract
Background: Multiple evidence synthesis organizations (ESO) exist with similar and overlapping missions. As a research center affiliated with multiple ESOs, navigating these sometimes competing priorities can be cumbersome and difficult.
Objectives: Develop a map of mission, vision, and priorities. Further, construct internal process improvement and funding to support our center's work as it aligns with multiple ESOs.
Methods: A map of convergent and divergent missions, visions, and priorities across our various ESO's was produced. This exercise included language analysis utilizing discourse analysis methods to ensure proper alignment with the ESOs published material. The results of this discourse analysis were then used to map critical terms to funding opportunities.
Results: Two key outcomes were realized. First, internal work products and priorities were better aligned to subject matter expertise, and work products were matched to key outcomes necessary to support our ongoing affiliation. Second, over $1,000,000.00 USD funding was obtained by leveraging the key strengths of our ESO partners.
Conclusion: Leveraging the key strengths of various ESOs can contribute to both internal process development and external recognition. The method development funded by our funding partner is critical to reducing health disparities, lessening the global burden of disease, and furthering the work of getting evidence into practice.
Objectives: Develop a map of mission, vision, and priorities. Further, construct internal process improvement and funding to support our center's work as it aligns with multiple ESOs.
Methods: A map of convergent and divergent missions, visions, and priorities across our various ESO's was produced. This exercise included language analysis utilizing discourse analysis methods to ensure proper alignment with the ESOs published material. The results of this discourse analysis were then used to map critical terms to funding opportunities.
Results: Two key outcomes were realized. First, internal work products and priorities were better aligned to subject matter expertise, and work products were matched to key outcomes necessary to support our ongoing affiliation. Second, over $1,000,000.00 USD funding was obtained by leveraging the key strengths of our ESO partners.
Conclusion: Leveraging the key strengths of various ESOs can contribute to both internal process development and external recognition. The method development funded by our funding partner is critical to reducing health disparities, lessening the global burden of disease, and furthering the work of getting evidence into practice.